CLINICAL_TRIALS
trial_result
· 2021-04-23
Clinical Trial Update: The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol [Phase 4]
Summary
Phase 4 clinical trial update on Replenix Power of Three With Resveratrol for acne vulgaris; study is terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yardley Dermatology Associates | Conditions: Acne Vulgaris | Phase 4 | Status: TERMINATED